Erythrocyte Raft Signaling In Malarial Infection
疟疾感染中的红细胞筏信号传导
基本信息
- 批准号:7173331
- 负责人:
- 金额:$ 9.37万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2005
- 资助国家:美国
- 起止时间:2005-02-21 至 2009-01-31
- 项目状态:已结题
- 来源:
- 关键词:AdhesivesAdrenergic AgentsAdrenergic ReceptorAfrican AmericanAnemiaApicalAtomic Force MicroscopyAttentionBiochemicalBiological AssayBiologyBlood CirculationBlood VesselsCellsChildCommunicable DiseasesComplexCouplingDevelopmentDiseaseEmployee StrikesErythrocyte MembraneErythrocytesEventFalciparum MalariaG-Protein-Coupled ReceptorsGasesGenesGeneticGenetic PolymorphismHematologyHemoglobinHeterotrimeric GTP-Binding ProteinsHumanImaging TechniquesInfectionLeadLigandsLipidsMalariaMembraneMembrane MicrodomainsMicrobial GeneticsModelingMolecularMolecular NanotechnologyOrganellesParasitesPathologyPhosphotransferasesPlasmodium falciparumPredispositionPrevalencePropertyProteinsRangeResistanceResistance to infectionResolutionReticulocytesSecond Messenger SystemsShapesSickle CellSignal PathwaySignal TransductionSignaling ProteinTherapeuticTransfectionTwo-Hybrid System TechniquesVacuoleVirulentYeastsadrenergicbaseconceptfunctional genomicsinformation gatheringinsightnovelparasite invasionprogramsreceptorsecond messengertool
项目摘要
DESCRIPTION (provided by applicant): Malaria is a major infectious disease. Conservative estimates predict that 2-300 million people are afflicted and over a million children die from the infection each year. Plasmodium falciparum causes the most virulent form of human malaria. A striking feature of P. falciparum is its infection of the mature erythrocyte. Despite the fact that this is a non-endocytic host cell, its signaling protein such as the heterotrimeric Gs and G protein coupled receptors (GPCRs) regulate infection of P. falciparum. The overall objective of this project is to develop a detailed understanding of the molecular and cellular mechanisms by which P. falciparum and malaria parasites induce signaling in erythrocytes. It is anticipated that study will lead to understanding how signaling via the erythrocyte heterotrimeric Gs protein confers susceptibility to malarial infection and pathology and thereby contribute to understanding the basic biology of the parasite as well as disease. Molecular, microbial genetic tools using transfection, functional genomics combined with high resolution imaging techniques, biochemical assays as well as expertise in hematology and host genetics, will be used to investigate mechanisms that lead to vacuole formation, modify basic membrane properties of the host erythrocyte and confer resistance against malaria. The information gathered in these studies may be important to understanding mechanisms that underlie development of therapeutic strategies against malarial infection and hemolytic disorders.
描述(申请人提供):疟疾是一种主要传染病。据保守估计,每年有2- 3亿人受到感染,100多万儿童死于感染。恶性疟原虫是最致命的人类疟疾。恶性疟原虫的一个显著特征是感染成熟红细胞。尽管这是一种非内吞宿主细胞,但其信号传导蛋白如异源三聚体Gs和G蛋白偶联受体(GPCR)调节恶性疟原虫的感染。该项目的总体目标是详细了解恶性疟原虫和疟原虫诱导红细胞信号传导的分子和细胞机制。预计这项研究将有助于了解通过红细胞异三聚体Gs蛋白的信号传导如何赋予疟疾感染和病理学的易感性,从而有助于了解寄生虫和疾病的基本生物学。利用转染、功能基因组学结合高分辨率成像技术、生物化学测定以及血液学和宿主遗传学方面的专门知识的分子、微生物遗传学工具将用于研究导致空泡形成、改变宿主红细胞的基本膜特性和赋予抗疟疾能力的机制。在这些研究中收集的信息可能是重要的,以了解机制的基础上发展的治疗策略,对疟疾感染和溶血性疾病。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KASTURI HALDAR其他文献
KASTURI HALDAR的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KASTURI HALDAR', 18)}}的其他基金
Malaria Phosphatase Inhibitors Identified as a Potential New Malaria Treatment
疟疾磷酸酶抑制剂被确定为潜在的新疟疾治疗方法
- 批准号:
8476279 - 财政年份:2012
- 资助金额:
$ 9.37万 - 项目类别:
Malaria Phosphatase Inhibitors Identified as a Potential New Malaria Treatment
疟疾磷酸酶抑制剂被确定为潜在的新疟疾治疗方法
- 批准号:
8262565 - 财政年份:2012
- 资助金额:
$ 9.37万 - 项目类别:
MECHANISMS OF ERYTHROCYTIC INFECTIONS AND ANEMIA: NHP MODEL MALARIAL ANEMIA
红细胞感染和贫血的机制:NHP 模型疟疾贫血
- 批准号:
8172365 - 财政年份:2010
- 资助金额:
$ 9.37万 - 项目类别:
Tubovesicular traffic induced in red cells in plasmodia
疟原虫红细胞中诱导的管泡交通
- 批准号:
8054523 - 财政年份:2010
- 资助金额:
$ 9.37万 - 项目类别:
MECHANISMS OF ERYTHROCYTIC INFECTIONS AND ANEMIA: NHP MODEL MALARIAL ANEMIA
红细胞感染和贫血的机制:NHP 模型疟疾贫血
- 批准号:
7958179 - 财政年份:2009
- 资助金额:
$ 9.37万 - 项目类别:
MECHANISMS OF ERYTHROCYTIC INFECTIONS AND ANEMIA: NHP MODEL MALARIAL ANEMIA
红细胞感染和贫血的机制:NHP 模型疟疾贫血
- 批准号:
7715763 - 财政年份:2008
- 资助金额:
$ 9.37万 - 项目类别:
MECHANISMS OF ERYTHROCYTIC INFECTIONS AND ANEMIA: NHP MODEL MALARIAL ANEMIA
红细胞感染和贫血的机制:NHP 模型疟疾贫血
- 批准号:
7562623 - 财政年份:2007
- 资助金额:
$ 9.37万 - 项目类别:
MECHANISMS OF ERYTHROCYTIC INFECTIONS AND ANEMIA: NHP MODEL MALARIAL ANEMIA
红细胞感染和贫血的机制:NHP 模型疟疾贫血
- 批准号:
7349291 - 财政年份:2006
- 资助金额:
$ 9.37万 - 项目类别:
Mechanisms of Erythrocytic Infection & Anemia in Malaria
红细胞感染的机制
- 批准号:
7282022 - 财政年份:2005
- 资助金额:
$ 9.37万 - 项目类别:
Mechanisms of Erythrocytic Infection & Anemia in Malaria
红细胞感染的机制
- 批准号:
7686865 - 财政年份:2005
- 资助金额:
$ 9.37万 - 项目类别:
相似海外基金
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
- 批准号:
8358448 - 财政年份:2012
- 资助金额:
$ 9.37万 - 项目类别:
Preclinical test for the efficacy of adrenergic agents in treatment of AD
肾上腺素能药物治疗AD疗效的临床前试验
- 批准号:
8517552 - 财政年份:2012
- 资助金额:
$ 9.37万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7952159 - 财政年份:2009
- 资助金额:
$ 9.37万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7952152 - 财政年份:2009
- 资助金额:
$ 9.37万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7719194 - 财政年份:2008
- 资助金额:
$ 9.37万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7605416 - 财政年份:2007
- 资助金额:
$ 9.37万 - 项目类别:
MODULATING FLUID THERAPY WITH ADRENERGIC AGENTS AND CYCLIC AMP ENHANCERS IN
使用肾上腺素能药物和环放大器增强剂调节液体治疗
- 批准号:
7605425 - 财政年份:2007
- 资助金额:
$ 9.37万 - 项目类别:
THE EFFECT OF BETA-ADRENERGIC AGENTS AND FLUID THERAPY IN HUMANS
β-肾上腺素能药物和液体疗法对人体的影响
- 批准号:
7378753 - 财政年份:2006
- 资助金额:
$ 9.37万 - 项目类别:
Adrenergic Agents for Methamphetamine: Outpatient Trials
甲基苯丙胺肾上腺素药物:门诊试验
- 批准号:
6825160 - 财政年份:2004
- 资助金额:
$ 9.37万 - 项目类别:
ADRENERGIC AGENTS FOR CARDIOPULMONARY RESUSCITATION
用于心肺复苏的肾上腺素能药物
- 批准号:
2702283 - 财政年份:1997
- 资助金额:
$ 9.37万 - 项目类别: